<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04610086</url>
  </required_header>
  <id_info>
    <org_study_id>PI18/00460</org_study_id>
    <nct_id>NCT04610086</nct_id>
  </id_info>
  <brief_title>Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study</brief_title>
  <acronym>CyDESA</acronym>
  <official_title>Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Context of the Colorectal Cancer Screening Program. The CyDESA Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cross sectional multicenter study (3 centers) to know the participation in decision making&#xD;
      and the experience and satisfaction of participants with a positive immunological fecal test&#xD;
      (FIT) result in relation to the screening process and the diagnostic-therapeutic process of&#xD;
      cancer.&#xD;
&#xD;
      We will include 850 participants with a positive FIT result and will classify them by their&#xD;
      final diagnosis (false positives of FIT; polyps; colo-rectal cancer).&#xD;
&#xD;
      Outcomes of interest will be measured by auto administered questionnaires:&#xD;
&#xD;
      collaboRATE, SDM-Q-9, OUT-PATSAT35 and a satisfaction questionnaire developed in a previous&#xD;
      study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 19, 2020</start_date>
  <completion_date type="Anticipated">December 19, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 19, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>Once the screening process is finished</time_frame>
    <description>Satisfaction with the colorectal cancer screening programm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participation in decision making</measure>
    <time_frame>Once the screening process is finished</time_frame>
    <description>Patient perception of participation in decision making during the screening process</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with diagnosis and treatment of cancer</measure>
    <time_frame>at 6 months</time_frame>
    <description>Satisfaction with the diagnostic and treatment processess of cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participation in cancer decision making</measure>
    <time_frame>at 6 months</time_frame>
    <description>Patient perception about participation in decision making during the diagnostic and treatment processess of cancer</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">850</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Satisfaction, Patient</condition>
  <arm_group>
    <arm_group_label>False positive FIT</arm_group_label>
    <description>Participants in the colorectal cancer screening program, with a positive FIT and with a normal colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polyps</arm_group_label>
    <description>Participants in the colorectal cancer screening program, with a positive FIT and diagnosed of colorectal polyps in the colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colorectal cancer</arm_group_label>
    <description>Participants in the colorectal cancer screening program, with a positive FIT diagnosed by colorectal cancer</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Participans in the colorectal cancer screening program with a positive results in the&#xD;
        immunological fecal test.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants in the colorectal cancer screening program, with a positive result in the&#xD;
             FIT AND in whom the perform of a colonoscopy is indicated AND agree to be included&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  People for whom the performance of a colonoscopy is not indicated by medical reasons&#xD;
&#xD;
          -  People who refuse to perform a colonoscopy&#xD;
&#xD;
          -  People who do not understand Spanish or Catalan, with deterioration of the cognitive&#xD;
             state that do not allow them to understand or answer the questionnaires on their own&#xD;
             or with the help of a caregiver;&#xD;
&#xD;
          -  People in which the process is not carried out completely in the study centers (eg.&#xD;
             performance of the colonoscopy in a private center).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>49 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anna Selva Olid, MD</last_name>
    <phone>937231010</phone>
    <phone_ext>22313</phone_ext>
    <email>aselva@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Selva Olid, MD</last_name>
      <phone>+34937231010</phone>
      <phone_ext>22313</phone_ext>
      <email>aselva@tauli.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Anna Selva</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

